Team:Calgary/Sandbox/Notebook/Journal/Detector
From 2013.igem.org
Azzucoloto (Talk | contribs) |
Azzucoloto (Talk | contribs) |
||
Line 18: | Line 18: | ||
<h2>Week 5: May 27 - May 31</h2> | <h2>Week 5: May 27 - May 31</h2> | ||
- | <p>We continued our literature search for a unique and stable pathogenic <i>E. coli marker for the TALEs to bind to. Potential pathogenic O157:H7 E. coli markers: stx1, stx2 (Yoshitomi et al., 2012), uidA (Yoshitomi et al., 2003 and Feng et al., 1994), eaeA, hly, rbfE (Fortin et al., 2000), and Z3276 (Li & Chen, 2012). However, BLAST searches determined that the use of only one 18 bp sequence is not sufficiently specific and sensitive to detect pathogenic markers. Should we continue to search for only one marker or more than one or expand the detection to any toxic shiga producing strains?</p><p>In addition to searching for a pathogenic E. coli marker, we also started working on the TALE sequence and its construction. The TALE sequence chosen has a truncation in both N- and C-terminus. The truncated N-terminus has 111 residues and the C-terminus, 42 residues (Meckler et al., 2013). The amino acid sequence was taken to obtain the nucleotide sequence optimized for E. coli. Codon optimization was performed by Integrated DNA Technologies (IDT). NEBCutter 2.0 was used to screen restriction sites for PstI, EcoRI, AgeI, NotI, XbaI, NgoMIV and SpeI, all present in the Freiburg RFC and for BsaI and Esp3I. The original TALE sequence has 11 cut sites: BsaI (3), PstI (1), EcoRI (1), Esp3I (4), AgeI (2). The restriction sites were then eliminated with silent mutations, based on a E. coli codon usage table (San Diego State University, 2012 modified from Maloy, Stewart & Taylor, 1996).</p><p>The large size of the TALE prevents simple cloning, therefore we looked to Golden Gate Assembly. Golden Gate Assembly is a subcloning strategy that uses type IIs restriction enzymes, which cut outside of their recognition sequence allowing ligation into a final product that lacks any specific recognition sites (Engler, Kandzia & Marillonnet, 2008).</p> | + | <p>We continued our literature search for a unique and stable pathogenic <i>E. coli</i> marker for the TALEs to bind to. Potential pathogenic O157:H7 <i>E. coli</i> markers: stx1, stx2 (Yoshitomi et al., 2012), uidA (Yoshitomi et al., 2003 and Feng et al., 1994), eaeA, hly, rbfE (Fortin et al., 2000), and Z3276 (Li & Chen, 2012). However, BLAST searches determined that the use of only one 18 bp sequence is not sufficiently specific and sensitive to detect pathogenic markers. Should we continue to search for only one marker or more than one or expand the detection to any toxic shiga producing strains?</p><p>In addition to searching for a pathogenic <i>E. coli</i> marker, we also started working on the TALE sequence and its construction. The TALE sequence chosen has a truncation in both N- and C-terminus. The truncated N-terminus has 111 residues and the C-terminus, 42 residues (Meckler et al., 2013). The amino acid sequence was taken to obtain the nucleotide sequence optimized for <i>E. coli</i>. Codon optimization was performed by Integrated DNA Technologies (IDT). NEBCutter 2.0 was used to screen restriction sites for PstI, EcoRI, AgeI, NotI, XbaI, NgoMIV and SpeI, all present in the Freiburg RFC and for BsaI and Esp3I. The original TALE sequence has 11 cut sites: BsaI (3), PstI (1), EcoRI (1), Esp3I (4), AgeI (2). The restriction sites were then eliminated with silent mutations, based on a E. coli codon usage table (San Diego State University, 2012 modified from Maloy, Stewart & Taylor, 1996).</p><p>The large size of the TALE prevents simple cloning, therefore we looked to Golden Gate Assembly. Golden Gate Assembly is a subcloning strategy that uses type IIs restriction enzymes, which cut outside of their recognition sequence allowing ligation into a final product that lacks any specific recognition sites (Engler, Kandzia & Marillonnet, 2008).</p> |
<h2>Week 6: June 3 - June 7</h2> | <h2>Week 6: June 3 - June 7</h2> |
Revision as of 23:15, 30 August 2013
TALEs Journal
Week 1: May 1 - May 3
Enter Text Here
Week 2: May 6 - May 10
Enter Text Here
Week 3: May 13 - May 17
Enter Text Here
Week 4: May 20 - May 24
We did our literature search for optimization of TALE binding affinity. There were conflicting results for the optimal truncation of the N and C terminus. On N terminus, 152 (Miller et al., 2011), 147 (Mussolini et al., 2011), 186 (Slovenia’s TALEs), and 158 or 186 (Mercer et al., 2012) residues were retained. On C terminus, 28 or 63 (Miller et al., 2011), and 76 (Slovenia’s TALEs) residues were retained. However, we did determine that residues 12 and 13 (repeat variable diresidues, RVDs) of the 34 amino acid repeats demonstrate polarity and interact more strongly with DNA at the N terminus compared to the C terminus (Meckler et al., 2013). As well, various amino acid permutations of the RVDs have varying interaction specificity and strengths.
The four TALEs designed by Slovenia 2012 iGEM team, were ordered from the registry. A primer was designed to incorporate the the target sequence of one of the Slovenia TALEs ([B]) upstream of a GFP generator. This plasmid was used as a target sequence. In addition, two other TALEs were ordered from the the authors of the Meckler et al. 2013 paper.
Week 5: May 27 - May 31
We continued our literature search for a unique and stable pathogenic E. coli marker for the TALEs to bind to. Potential pathogenic O157:H7 E. coli markers: stx1, stx2 (Yoshitomi et al., 2012), uidA (Yoshitomi et al., 2003 and Feng et al., 1994), eaeA, hly, rbfE (Fortin et al., 2000), and Z3276 (Li & Chen, 2012). However, BLAST searches determined that the use of only one 18 bp sequence is not sufficiently specific and sensitive to detect pathogenic markers. Should we continue to search for only one marker or more than one or expand the detection to any toxic shiga producing strains?
In addition to searching for a pathogenic E. coli marker, we also started working on the TALE sequence and its construction. The TALE sequence chosen has a truncation in both N- and C-terminus. The truncated N-terminus has 111 residues and the C-terminus, 42 residues (Meckler et al., 2013). The amino acid sequence was taken to obtain the nucleotide sequence optimized for E. coli. Codon optimization was performed by Integrated DNA Technologies (IDT). NEBCutter 2.0 was used to screen restriction sites for PstI, EcoRI, AgeI, NotI, XbaI, NgoMIV and SpeI, all present in the Freiburg RFC and for BsaI and Esp3I. The original TALE sequence has 11 cut sites: BsaI (3), PstI (1), EcoRI (1), Esp3I (4), AgeI (2). The restriction sites were then eliminated with silent mutations, based on a E. coli codon usage table (San Diego State University, 2012 modified from Maloy, Stewart & Taylor, 1996).
The large size of the TALE prevents simple cloning, therefore we looked to Golden Gate Assembly. Golden Gate Assembly is a subcloning strategy that uses type IIs restriction enzymes, which cut outside of their recognition sequence allowing ligation into a final product that lacks any specific recognition sites (Engler, Kandzia & Marillonnet, 2008).
Week 6: June 3 - June 7
Enter Text Here
Week 7: June 10 - June 14
Enter Text Here
Week 8: June 17 - June 21
Enter Text Here
Week 9: June 24 - June 28
Enter Text Here
Week 10: July 1 - July 5
Enter Text Here
Week 11: July 8 - July 12
Enter Text Here
Week 12: July 15 - July 19
Enter Text Here
Week 13: July 22 - July 26
Enter Text Here
Week 14: July 29 - August 2
Enter Text Here
Week 15: August 5 - August 9
Enter Text Here
Week 16: August 12 - August 16
Enter Text Here
Week 17: August 19 - August 23
Enter Text Here
Week 18: August 26 - August 30
Enter Text Here
Week 19: September 2 - September 6
Enter Text Here
Week 20: September 9 - September 13
Enter Text Here
Week 21: September 16 - September 20
Enter Text Here
Week 22: September 23 - September 27
Enter Text Here
Week 23: September 30 - October 4
Enter Text Here